First-Ever Treatment for Ultra-Rare Rapid-Aging Disease Progeria Receives Approval in Japan
/PRNewswire/ -- The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of...
Source: prnewswire.com